EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Socioeconomic Determinants of Vaccination Against Pneumococcus in 763 945 Patients with Heart Failure

F Roubille, B Wyplosz, J Fernandes, B Grenier, F Raguideau, E Blanc, G Goussiaume

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15381 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ESC Heart Failure, 2025. Verfasst von F Roubille und 6 weiteren Autor:innen. Beteiligte Einrichtung: PhyMedExp, Cardiology Department, University of Montpellier, INSERM U1046, CNRS UMR, Montpellier, France. Hauptthemen laut MEDLINE: Heart Failure, Pneumococcal Vaccines, Vaccination, Pneumococcal Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pfizer France.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory infections are the leading cause of acute decompensation, hospitalization and higher mortality in heart failure (HF) patients. Despite recommendations, vaccination coverage against pneumococcus and influenza remains alarmingly low (3% and 50% in 2018, respectively). This study aimed to identify factors associated with vaccination among HF patients using data from the Nationwide Health Claims Database for 2020, in France. The patients were followed during the entire year 2020. At least one dose of PCV13 was considered as a proxy for vaccination. The model used was a multivarable logistic regression. Among 763 945 HF patients (mean age 76.7 years, 54.2% male), the mean annual visits were 7.0 with a general practitioner, 1.68 with a specialist and 70.0 with a nurse. Despite frequent healthcare contacts, vaccination coverage was only 12.6% for pneumococcus (PCV13) and 63.1% for influenza. In multivariable analyses, at least one dose of the PCV13 was less often received when patients were (1) older (odd ratio (OR): 0.71 [0.67; 0.74], P < 0.0001 and 0.48 [0.46; 0.51], P < 0.0001) in patients 76–85 and older than 85 years old, respectively, (2) women (OR: 0.916 [0.903; 0.929], P < 0.0001) or 3/when they presented social deprivation (for the quintile Q5 of deprivation index, OR was 0.893 [0.872; 0.914], P < 0.0001). Pneumoccocus vaccination was associated with influenza vaccination or with better access to health services. We need to consider factors, such as age, sex and social deprivation, to adapt public health initiatives supporting a significantly and sustainably increase pneumococcal vaccination coverage in frail HF patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailurePneumococcal VaccinesVaccinationPneumococcal InfectionsStreptococcus pneumoniaeVaccination CoverageHumansMaleFemaleAgedFranceAged, 80 and overSocioeconomic FactorsRetrospective Studies

Stichwörter der Autor:innen

ElderliesHeart failureIncentive campaignNationwide databasePneumococcusSocial deprivationVaccination

Substanzen

Pneumococcal Vaccines

Autor:innen und Institutionen

  • PhyMedExp, Cardiology Department, University of Montpellier, INSERM U1046, CNRS UMR, Montpellier, France.
  • AP-HP, Hospitalisation à domicile, Institut Pasteur de Paris, Paris, France.
  • CH Cote Basque, Bayonne, France.
  • Epidemiology Department, Heva, Lyon, France.
  • Pfizer, Paris, France.

Förderung

  • Pfizer France

Zitieren

APA

Roubille, F., Wyplosz, B., Fernandes, J., Grenier, B., Raguideau, F., Blanc, E., & Goussiaume, G. (2025). Socioeconomic Determinants of Vaccination Against Pneumococcus in 763 945 Patients with Heart Failure. ESC Heart Failure. https://doi.org/10.1002/ehf2.15381

Vancouver

Roubille F, Wyplosz B, Fernandes J, Grenier B, Raguideau F, Blanc E, et al. Socioeconomic Determinants of Vaccination Against Pneumococcus in 763 945 Patients with Heart Failure. ESC Heart Failure. 2025. doi:10.1002/ehf2.15381

BibTeX
@article{Roubille2025,
  author = {Roubille, F and Wyplosz, B and Fernandes, J and Grenier, B and Raguideau, F and Blanc, E and Goussiaume, G},
  title = {Socioeconomic Determinants of Vaccination Against Pneumococcus in 763 945 Patients with Heart Failure},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15381}
}
Kostenlos starten →